Table 2.
Mean, minimum, maximum, median, and quartile ratings for the study population’s age, number of treatment cycles, and duration of therapies
| No. of patients | Variable | Mean | Minimum | Maximum | Median | Lower quartile | Upper quartile |
|---|---|---|---|---|---|---|---|
| 71 | Age (years) | 68.7 | 44.0 | 90.0 | 70.5 | 61.5 | 78.0 |
| 71 | Duration of therapy (months) | 33.9 | 1.0 | 300.0 | 18.0 | 11.0 | 31.0 |
| 65 | Bisphosphonates (cycles) | 34.2 | 2.0 | 360.0 | 19.0 | 8.0 | 28.0 |
| 6 | Denosumab (cycles) | 14.7 | 1.0 | 34.0 | 12.0 | 7.0 | 25.0 |
| 25 | Bisphosphonates switched to | 21.5 BP | 3.0 BP | 67.0 BP | 21.0 BP | 6.5 BP | 26 BP |
| Denosumab (cycles) | 13.6 D | 1.0 D | 34.0 D | 11.0 D | 6.0 D | 17.5 D |